Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine HCl

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Particulate Matter
Products
  • R.E.C.K. (Ropivacaine HCl
Where it was sold

U.S. Nationwide

Nationwide

Units affected
75,885 syringes
About this recall
R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sodium Chloride Solution, Total Volume: 50 mL syringe. INJECTION FOR PERIARTICULAR USE; Not for IV Use. THIS IS A COMPOUNDED DRUG. QuVA Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, TX 77478. NDC 70092-1433-50